Phase I trial of valproic acid and epirubicin in solid tumor malignancies
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Epirubicin; Fluorouracil; Valproic acid
- Indications Solid tumours
- Focus Adverse reactions
- 23 Feb 2017 Biomarkers information updated
- 27 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.